118 related articles for article (PubMed ID: 29136767)
1. The exposure-effect-toxicity correlation of docetaxel and magnesium isoglycyrrhizinate in non-small cell lung tumor-bearing mice.
Li P; Li S; Gu H; Lu Q; Jiang W; Pei X; Sun Y; Xu H; Wang G; Hao K
Biomed Pharmacother; 2018 Jan; 97():1000-1010. PubMed ID: 29136767
[TBL] [Abstract][Full Text] [Related]
2. Multiple effects of magnesium isoglycyrrhizinate on the disposition of docetaxel in docetaxel-induced liver injury.
Qu B; Xing R; Wang H; Chen X; Ge Q; Peng D; Wang G
Xenobiotica; 2017 Apr; 47(4):290-296. PubMed ID: 27218144
[TBL] [Abstract][Full Text] [Related]
3. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.
Sui M; Jiang X; Chen J; Yang H; Zhu Y
Biomed Pharmacother; 2018 Oct; 106():125-133. PubMed ID: 29957462
[TBL] [Abstract][Full Text] [Related]
4. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
[TBL] [Abstract][Full Text] [Related]
5. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Lee E; Kim H; Lee IH; Jon S
J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
[TBL] [Abstract][Full Text] [Related]
6. Magnesium isoglycyrrhizinate prevents cadmium-induced activation of JNK and apoptotic hepatocyte death by reversing ROS-inactivated PP2A.
Chen X; Wang X; Yang L; Xu H; Wu Y; Wu J; Chen L; Xu C
J Pharm Pharmacol; 2021 Dec; 73(12):1663-1674. PubMed ID: 34468764
[TBL] [Abstract][Full Text] [Related]
7. Magnesium isoglycyrrhizinate ameliorates concanavalin A-induced liver injury via the p38 and JNK MAPK pathway.
Gao Y; Tian Y; Zhang X; Zhang X; Duan Z; Ren F; Chen Y
Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):445-455. PubMed ID: 32787473
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation.
Li L; Zhou J; Li Q; Xu J; Qi J; Bian H
Biomed Pharmacother; 2018 Oct; 106():83-91. PubMed ID: 29957470
[TBL] [Abstract][Full Text] [Related]
9. Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol-induced hepatocyte steatosis and apoptosis.
Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
IUBMB Life; 2017 Jul; 69(7):540-552. PubMed ID: 28500689
[TBL] [Abstract][Full Text] [Related]
10. Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema.
Lim HK; Kim KM; Jeong SY; Choi EK; Jung J
Integr Cancer Ther; 2017 Dec; 16(4):496-504. PubMed ID: 27151585
[TBL] [Abstract][Full Text] [Related]
11. Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin‑induced model of liver injury.
Zou X; Wang Y; Peng C; Wang B; Niu Z; Li Z; Niu J
Int J Mol Med; 2018 Oct; 42(4):2020-2030. PubMed ID: 30066834
[TBL] [Abstract][Full Text] [Related]
12. Magnesium isoglycyrrhizinate inhibits inflammatory response through STAT3 pathway to protect remnant liver function.
Tang GH; Yang HY; Zhang JC; Ren JJ; Sang XT; Lu X; Zhong SX; Mao YL
World J Gastroenterol; 2015 Nov; 21(43):12370-80. PubMed ID: 26604644
[TBL] [Abstract][Full Text] [Related]
13. Protective effects against and potential mechanisms underlying the effect of magnesium isoglycyrrhizinate in hypoxia-reoxygenation injury in rat liver cells.
Zheng J; Wu G; Hu GX; Peng YZ; Xiong XJ
Genet Mol Res; 2015 Dec; 14(4):15453-61. PubMed ID: 26634511
[TBL] [Abstract][Full Text] [Related]
14. Magnesium Isoglycyrrhizinate Reduces Hepatic Lipotoxicity through Regulating Metabolic Abnormalities.
Lu L; Hao K; Hong Y; Liu J; Zhu J; Jiang W; Zhu Z; Wang G; Peng Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070938
[TBL] [Abstract][Full Text] [Related]
15. Magnesium Isoglycyrrhizinate Alleviates Arsenic Trioxide-Induced Cardiotoxicity: Contribution of Nrf2 and TLR4/NF-κB Signaling Pathway.
Zheng B; Yang Y; Li J; Li J; Zuo S; Chu X; Xu S; Ma D; Chu L
Drug Des Devel Ther; 2021; 15():543-556. PubMed ID: 33603344
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activity of high-dose EGFR tyrosine kinase inhibitor and sequential docetaxel in wild type EGFR non-small cell lung cancer cell nude mouse xenografts.
Tang N; Zhang Q; Fang S; Han X; Wang Z
Oncotarget; 2017 Feb; 8(6):9134-9143. PubMed ID: 27852073
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two kinds of docetaxel-vitamin E prodrugs: In vitro evaluation and in vivo antitumor activity.
Wang J; Xue P; Zhou J; Li L; Xu L; Wang Y
Int J Pharm; 2016 May; 505(1-2):352-60. PubMed ID: 27085643
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha improves docetaxel antitumoral and antimetastatic efficiency in Lewis lung carcinoma bearing mice.
Ben Reguiga M; Bouquet C; Farinotti R; Bonhomme-Faivre L
Life Sci; 2012 Oct; 91(17-18):843-51. PubMed ID: 23047021
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-Pharmacodynamic Modeling of the Anti-Tumor Effect of Sunitinib Combined with Dopamine in the Human Non-Small Cell Lung Cancer Xenograft.
Hao F; Wang S; Zhu X; Xue J; Li J; Wang L; Li J; Lu W; Zhou T
Pharm Res; 2017 Feb; 34(2):408-418. PubMed ID: 27975187
[TBL] [Abstract][Full Text] [Related]
20. Magnesium isoglycyrrhizinate protects hepatic L02 cells from ischemia/reperfusion induced injury.
Huang X; Qin J; Lu S
Int J Clin Exp Pathol; 2014; 7(8):4755-64. PubMed ID: 25197346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
